CIPLA Q4 FY26 Guidance vs Delivery (CIPLA Management Mirror)

Did CIPLA's management deliver what it guided? Guidance vs actual performance and tone changes across recent earnings calls, as of the Q4 FY26 (Mar-2026 Qtr) concall.

  • CIPLA Financials
  • CIPLA Shareholding Pattern
  • CIPLA Earnings Documents
  • CIPLA Announcements
  • CIPLA Corporate Actions
  • CIPLA Bulk, Block & Insider Deals
  • CIPLA Delivery Data
  • CIPLA Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Cipla Ltd (CIPLA) Q4FY26 Management Mirror - Mar-2026 Qtr

US Revenue Outlook

Management targets a $1 billion revenue run rate by the end of FY27, reaffirming the timeline previously withdrawn in the Dec'25 Qtr due to supply disruptions, though the renewed Mar'26 Qtr target now explicitly excludes any Lanreotide contributions. [Status: Reaffirmed]

5 more themes on the ELITE plan.

  • CIPLA Q4FY26 Concall Summary
  • CIPLA Q4FY26 Concall Transcript
  • CIPLA Q3FY26 Management Mirror (Dec-2025 Qtr)
  • CIPLA Q1FY27 Management Mirror (Jun-2026 Qtr)